INTRODUCTION
In areas of moderate to high malaria endemicity, naturally-acquired immunity to malaria is characterized by protection against clinical disease and control of high density parasitaemia [1, 2] . Antibodies play a major role in naturally-acquired immunity to Plasmodium falciparum malaria [1, 2] and predominantly target the blood-stages, including merozoites and infected erythrocytes (IEs). Anti-malarial antibodies typically increase with age, exposure and transmission intensity and the link between antibody acquisition and the level of malaria exposure has been largely established (reviewed in [3] , [4] ). As a result of intensified control efforts, and other factors (e.g. change in malaria policies and practices, changes in users' and health providers' behaviours), P.falciparum transmission has declined in many regions in recent years, and these declines have been associated with higher rates and severity of clinical malaria [5] [6] [7] , which may be attributed to declining naturally-acquired immunity in populations. While there is evidence that declines in malaria transmission are associated with reductions in antibodies to blood-stage antigens [8] [9] [10] , what is less clear is how rapidly antibody levels to different targets decline in the context of declining transmission, whether significant humoral immune responses are maintained after reductions in transmission, or the impact of changing transmission on functional antibody responses.
Reported estimated half-lives of antibodies to blood-stage malaria antigens range from weeks to years (reviewed in [3] ). These data are mainly for merozoite antigens, whereas there are limited data on the maintenance of functional antibody responses associated with protection (e.g. opsonisation of merozoites for phagocytic clearance and complement fixation on merozoites) [11, 12] . The maintenance and function of antibodies to IE surface antigens or merozoite antigens might be impacted by their different presentation to the immune system, but there are Downloaded from https://academic.oup.com/jid/article-abstract/doi/10.1093/infdis/jix370/4060521/Declining-malaria-transmission-differentially by Swansea University user on 07 September 2017 A c c e p t e d M a n u s c r i p t 6 limited data comparing the decay of antibodies to different blood-stage antigens. Also, different kinetics of antibody responses specific for different alleles might give some indication of the relative prevalence and dynamics of circulating parasite strains, and antibody decay rates for different alleles may vary [13, 14] . Greater knowledge on how declining malaria transmission affects maintenance of immunity, especially functional immune responses, is required in order to identify biomarkers of exposure, evaluate the impact of interventions, and help identify populations at risk (reviewed in [4] ), as well as inform the development of long-lasting vaccines.
Here, we examined the impact of declining P. falciparum transmission on the maintenance of antibodies to P. falciparum antigens in a 3-year longitudinal cohort of Kenyan children. We measured antibody responses to two representative merozoite antigens, apical membrane antigen 1 (AMA1) and merozoite surface protein 2 (MSP2). The two antigens are important targets of naturally-acquired antibodies, including functional antibodies, that have been associated with protection against clinical disease in our study population [11, 15, 16] , and are established vaccine candidates [17, 18] . We included different alleles of AMA1 and MSP2 to assess patterns of allele-specific antibodies over time. We examined the acquisition of antibody responses in relation to age and parasitaemia over time, and calculated antibody decay rates.
Furthermore, we determined the maintenance of functional antibodies to merozoites and compared maintenance of antibodies between merozoite and IE surface antigens to determine whether different response-types are maintained differently.
METHODS

Study design and population
Downloaded from https://academic.oup.com/jid/article-abstract/doi/10.1093/infdis/jix370/4060521/Declining-malaria-transmission-differentially by Swansea University user on 07 September 2017 The same children were seen at most time points and 186 children were present at all 6 sampling points. At each time-point, presence of P. falciparum parasitaemia was assessed among all children by light microscopy. Active malaria case detection was performed weekly; children who were febrile (temperature ≥ 37.5°C) or had a recent history of fever or illness had a blood smear performed. Malaria was defined as any parasitaemia with fever in children <1 year and a parasitaemia ≥2,500/µl of blood with fever in children ≥1 year [20] . Ethics approval was For cross-sectional analyses of antibody prevalence at each time-point, all available children were included (n=270 to 298). For longitudinal analysis of changes in antibody levels over time, only children who were sampled at all time points were included (n=186). For estimating antibody half-life during a period of minimal malaria transmission, only children who were sampled at all three time-points that corresponded to the decline in malaria prevalence 
Antibody measurements
IgG among serum samples was measured by standard ELISA, as described [21] using recombinant AMA1 (W2mef, HB3, and 3D7 alleles) and MSP2 (3D7 and FC27 alleles), which were expressed in E. coli [15, 22] . For functional antibodies to merozoites we used intact purified merozoites of the D10 isolate [23] . Merozoite opsonic phagocytosis was performed as described elsewhere [24] . Antibody-mediated fixation of C1q to the surface of merozoites, a biomarker of classical complement activation that leads to inhibition of merozoite invasion and merozoite lysis, was measured as described [25] . IgG reactivity to surface antigens of IEs (3D7 and IT4var19 isolates) was evaluated using an established flow-cytometry-based approach [26] .
Further details are provided in Supplementary Methods.
Data Analysis
Analyses were performed using STATA software. Antibody sero-positivity threshold was defined as the mean reactivity of negative controls plus 3 standard deviations [27] . Prevalence of antibodies to AMA1 and MSP2 between different age groups and different time-points were compared using the Chi-square test. Antibody levels across groups at a single time point were compared using Kruskal-Wallis and Mann-Whitney tests. MANOVA for repeated measures using the Wilks Lambda criteria was used to test for differences in antibody levels over time on the T -1 absolute differences between subsequent measurements. Estimated mean antibodies half-lives were determined from linear mixed effect models as previously described [21] .
RESULTS
M
a n u s c r i p t Table S2 ).
This decline in transmission was accompanied by significant reductions in the prevalence of antibodies to all AMA1 ( Table 1 ) and MSP2 alleles (Table 2) within most age groups over that period (2-8-year olds for AMA1 and MSP2-FC27; 3 and 5-7-year olds for MSP2-3D7). Despite declining transmission and immune responses, AMA1 and MSP2 antibody prevalence and levels were consistently higher among older children at every time point (Table 1 and 2; P < 0.001 to P = 0.033; P < 0.001, respectively), such that median antibody levels were significantly higher amongst 7-10-year olds compared with 1-3-year olds (P < 0.001; Tables 2,   3 , S3, S4 and S5). Similar associations with age were observed for antibody responses to all alleles of AMA1 and MSP2 and to schizont protein extract used as a proxy for P. falciparum blood-stage exposure (Table S6 ). The prevalence of antibodies to MSP2-3D7 was higher than to MSP2-FC27 allele, reflecting the moderately higher prevalence of MSP2-3D7 genotype infections in the study population [28] .
A c c e p t e d M a n u s c r i p t sampling had higher levels of antibodies to all alleles of AMA1 (Tables 3, 4, S3) and MSP2 (Tables 4, S5) compared to aparasitaemic children (P < 0.01). This suggests that on-going exposure to infection helped maintain higher levels in the cohort, and the declining transmission and exposure therefore resulted in declining antibody levels. Associations between antibodies and increasing age were observed in aparasitaemic children, but less consistently amongst parasitaemic children. Similar results were observed for antibody responses to all alleles of MSP2 and AMA1 and to schizont extract (Table S6) .
Decay rates of antibodies to merozoite antigens with declining malaria transmission
We examined the rate of decline of levels and prevalence of antibodies to AMA1 and 
Maintenance of functional antibodies to merozoites and antibodies to infected erythrocytes surface antigens
We evaluated maintenance of functional antibodies to merozoites as malaria transmission declined. We studied antibodies that promote opsonic phagocytosis of merozoites and antibodies We measured levels of antibodies to surface antigens of IEs given they could be maintained differently to merozoite antigens due to their different presentation to the immune system ( Figures 2C, 2D ). We previously reported that these antibodies are acquired in an agedependent manner [12, 24] in our study population and predominantly target PfEMP1 [30, 31].
We included two genetically distinct isolates expressing PfEMP1 types associated with virulent phenotypes and disease pathogenesis: i) isolate IT4var19 expresses var19 (containing a DC8 arrangement) which mediates adhesion to cerebral endothelial cells; ii) a 3D7 isolate we identified that expresses group A var genes (including a DC13 arrangement) associated with virulent properties (Table S1 ). Antibodies to IE surface antigens expressed by both isolates were relatively stable as malaria transmission declined (half-lives 10. Collectively these results show that while total levels of antibodies to individual merozoite antigens are sensitive to changes in malaria transmission, specific antibody functional activity is better maintained, especially their capacity to fix complement. Antibodies to IEs M a n u s c r i p t 13 expressing PfEMP1 variants associated with disease pathogenesis also appear to be better maintained.
DISCUSSION
There is concern that recent reductions in malaria transmission in many endemic countries [6, [32] [33] [34] [35] ] may lead to rapid declines in naturally-acquired immunity, leaving many at increased risk of malaria and severe complications. Declining P. falciparum prevalence in our cohort was accompanied by decreasing antibodies to two key merozoite antigens, AMA1 and MSP2; this was consistent across different alleles of MSP2 and AMA1. In the context of low parasite prevalence and absence of clinical malaria, most children maintained seropositivity to AMA1, whereas fewer children retained seropositivity for MSP2. The broad similarity in estimated half-lives of antibodies to AMA1 and MSP2 (approximately 9 months and 1-3 years, respectively, with overlapping confidence intervals) suggests that differences in maintenance of sero-positivity could be related to lower starting levels of antibodies to MSP2. Different kinetics of antibody responses specific for different alleles might give some indication of the relative prevalence and dynamics of circulating parasite strains [13, 14] . M a n u s c r i p t 14 Rather than determining absolute decay rates of antibodies in the absence of any exposure, we estimated antibody maintenance in a practical setting where malaria transmission had dramatically reduced, an increasingly common situation globally. Maintenance of antibodies was highly variable among individuals, from rapid decay to no decline. Overall estimated halflives of 1-3 years for antibodies to AMA1 or MSP2 indicate that antibodies to merozoite antigens decline relatively quickly; however, such decay rates and the wide variation in antibody maintenance among individuals imply that detectable levels of these antibodies could be maintained for several years. Our findings are largely consistent with studies in pregnant women
[21] and a small study of adults in South-East Asia [36] . In contrast, some studies in African children reported rapid declines in antibodies to merozoite antigens when measured immediately after treatment for acute malaria [37, 38] . Given antibodies initially decay rapidly following an acute infection, estimates of antibody half-lives will be much shorter if measured following an acute episode than measured in uninfected subjects as we have done [3, 39, 40] . Published evidence suggests impairment in the induction of B cell memory to malaria [41] , which may partly explain the lack of sustained responses.
We complemented observations on the dynamics of antibody levels by providing important new data on maintenance of functional antibodies to merozoite antigens on which very little is currently known. We measured antibodies that mediate opsonic phagocytosis and complement fixation on merozoites as these have emerged as likely mechanisms of immunity and promising functional correlates of immunity [12, 24, 25, 29] . Functional complement-fixing antibodies to merozoites were better maintained than total antibodies to merozoite antigens. This may suggest that complement fixation requires only low levels of antibodies and antibody levels must decline below a certain threshold before functional activity is lost. Alternatively, M a n u s c r i p t 15 complement fixation might be mediated by specific antibodies that are better maintained over time due to their role in immunity. Functional activity is dependent on multiple antibody properties, such as affinity, subclass, allotype, glycosylation, and epitope specificity, and not just total antibody levels [42] . In contrast, opsonic phagocytosis-promoting antibodies rapidly declined, suggesting this functional response is more sensitive to decrease in antibody levels.
However, most children remained positive for opsonic phagocytosis activity over the 12-month period even though overall activity did decline quickly. While antibody decay was estimated among children who had no parasitaemia detected during surveillance using microscopic evaluation of blood smears, it is possible that we missed some parasitaemic events; data on parasitaemia detected using more sensitive PCR methods was not available. Our findings indicate that some forms of immunity may be better maintained, and highlight the need for assessing antibody function in population studies rather than simply antibody levels. The sustained persistence of some key elements of immunity is consistent with epidemiologic evidence suggesting that some level of immunity may be maintained for extended periods after decline or interruption malaria transmission [3] .
Our previous studies showed that the prevalence of growth-inhibitory antibodies in this cohort was low [43] ; therefore these were not evaluated. However, we previously showed that growth-inhibitory antibodies were higher at times of higher malaria transmission [43]. It was not possible to investigate the relationship between declining immunity and subsequent risk of malaria in this study. Prior studies [15, 44] have suggested that there is a threshold magnitude of antibodies required to mediate immunity. Our results finding a decline in total antibodies to merozoites suggest that susceptibility to malaria is likely to have increased in children as a result of this decline. M a n u s c r i p t 16 Antibody acquisition longevity may also vary according to antigen specificity and parasite life-stage [21, 38, 45]; therefore we compared maintenance of antibodies to merozoite antigens versus IE surface antigens. For our studies we used isolates that expressed PfEMP1 variants associated with disease pathogenesis as we reasoned that antibodies to these variants are likely to have a role in immunity. Levels of antibodies to IE surface antigens were better maintained than levels of antibodies to merozoite surface antigens despite a lower sero-positivity at the beginning of the study. This may be due to their different presentation to the immune system and suggests that some individuals can maintain effective antibody-mediated immunity to IE surface antigens. We have previously reported that the majority (>80%) of antibody reactivity M a n u s c r i p t 31 
